TD Ameritrade Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-741
| Closed | -$85K | – | 741 |
|
|
2021
Q3 | $85K | Buy |
741
+714
| +2,644% | +$81.9K | ﹤0.01% | 275 |
|
|
2021
Q2 | $5K | Sell |
27
-637
| -96% | -$118K | ﹤0.01% | 535 |
|
|
2021
Q1 | $104K | Hold |
664
| – | – | ﹤0.01% | 267 |
|
|
2020
Q4 | $104K | Sell |
664
-77
| -10% | -$12.1K | ﹤0.01% | 267 |
|
|
2020
Q3 | $85K | Buy |
741
+154
| +26% | +$17.7K | ﹤0.01% | 275 |
|
|
2020
Q2 | $66K | Buy |
587
+9
| +2% | +$1.01K | ﹤0.01% | 283 |
|
|
2020
Q1 | $52K | Buy |
578
+97
| +20% | +$8.73K | ﹤0.01% | 290 |
|
|
2019
Q4 | $52K | Buy |
481
+94
| +24% | +$10.2K | ﹤0.01% | 313 |
|
|
2019
Q3 | $38K | Buy |
387
+360
| +1,333% | +$35.3K | ﹤0.01% | 317 |
|
|
2019
Q2 | $4K | Sell |
27
-19
| -41% | -$2.82K | ﹤0.01% | 528 |
|
|
2019
Q1 | $6K | Sell |
46
-1
| -2% | -$130 | ﹤0.01% | 434 |
|
|
2018
Q4 | $5K | Buy |
47
+9
| +24% | +$957 | ﹤0.01% | 460 |
|
|
2018
Q3 | $5K | Buy |
38
+30
| +375% | +$3.95K | ﹤0.01% | 410 |
|
|
2018
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 456 |
|